Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Belangrijke stappen in onderzoek behandeling MS en alzheimer
sep 2019 | Dementie, Multipele Sclerose